Skip to content
Smart Scholars🛡 Scholar Shield🏛 Research Integrity Desk🧩 Portfolio Console📰 Journals🔧 DOI MembersTools🔎 Journal AuditGI GetIndexedDr DOI Doctor

Cite this DOI

10.46243/jst.2025.v10.i6.pp37-47 · AntimicrobialResistanceProfileofDifferentClinicalIsolatesagainstThird-GenerationCephalosporins

APA (7th edition)

DRBVRAMANA, S.K.RUBINA, DRMSANTOSHRAJA, AHEMANTH, & S.AFREENJEHA (2025). AntimicrobialResistanceProfileofDifferentClinicalIsolatesagainstThird-GenerationCephalosporins. *Journal of Science & Technology*, *10*(06), 37–47. https://doi.org/10.46243/jst.2025.v10.i6.pp37-47

⬇ text Italics are shown as *asterisks* in plain text — the journal or book title and the volume.

BibTeX

@article{drbvramana2025antimicrobialresistanceprofileofdifferentclinicalisolatesagainstthirdgenerationcephalosporins,
  author    = {DRBVRAMANA and S.K.RUBINA and DRMSANTOSHRAJA and AHEMANTH and S.AFREENJEHA},
  title     = {{AntimicrobialResistanceProfileofDifferentClinicalIsolatesagainstThird-GenerationCephalosporins}},
  journal   = {Journal of Science \& Technology},
  year      = {2025},
  month     = {jun},
  volume    = {10},
  number    = {06},
  pages     = {37--47},
  publisher = {Longman Publishers},
  issn      = {2456-5660},
  doi       = {10.46243/jst.2025.v10.i6.pp37-47},
  url       = {https://doi.org/10.46243/jst.2025.v10.i6.pp37-47},
  language  = {en},
  abstract  = {death because they increase the likelihood of harmful treatment. Antimicrobial resistance statistics therefore aid in determining optimal patient care. Consequently, the purpose of this research was to examine the antimicrobial resistance pattern of third-generation cephalosporin medications at Jimma University Specialized Teaching Hospital. Methods. From April to August 2016, researchers at Jimma University Specialized Hospital (JUSH) performed a prospective cross-sectional study in a hospital setting. Patients in hospitals had their urine, sputum, wound swabs, and feces collected for clinical purposes. Following this, the usual microbiological procedures were followed in order to isolate and identify the bacterial species. Using the Kirby-Bauer disc diffusion technique, we tested the susceptibility of different microorganisms to antimicrobials. Final product. Out of a total of 248 bacterial isolates, 154 (62.1\%) were found in male patients and 94 (37.0\%) were found in female patients. Specimens were most often found to include Escherichia coli (25.4\% of the total) and Staphylococcus aureus (19.0\%). Approximately 56.5\% of the total bacterial isolates (140) and 60.1\% (149) were determined to be ceftriaxone and ceftazidime resistant, respectively. Most of the Escherichia coli isolates were resistant to ceftriaxone (73\%) and ceftazidime (65\%), with 41 (65\%) of the isolates showing resistance to both drugs. Of all the germs tested, 19\% were Staphylococcus aureus, and of those, 23.4 percent were resistant to ceftriaxone and 33.4 percent to ceftazidime, respectively. Out of the bacterial strains that showed resistance to ceftriazone and ceftazidime, about 109 (44\% of the total) were also resistant to two, three, or four additional medicines. In summary. More and more bacterial strains are showing resistance to thirdgeneration cephalosporins, such as ceftriaxone and ceftazidime. This indicates that the problem is becoming worse. Treatment may fail because some bacteria have shown multidrug resistance, especially to medicines used in clinical settings. Thus, antimicrobial susceptibility test results should inform the selection of suitable drugs for clinical usage}
}

⬇ .bib

RIS (EndNote, Zotero, Mendeley)

TY  - JOUR
TI  - AntimicrobialResistanceProfileofDifferentClinicalIsolatesagainstThird-GenerationCephalosporins
AU  - DRBVRAMANA
AU  - S.K.RUBINA
AU  - DRMSANTOSHRAJA
AU  - AHEMANTH
AU  - S.AFREENJEHA
JO  - Journal of Science & Technology
PY  - 2025
DA  - 2025/06/20/
VL  - 10
IS  - 06
SP  - 37
EP  - 47
PB  - Longman Publishers
SN  - 2456-5660
LA  - en
AB  - death because they increase the likelihood of harmful treatment. Antimicrobial resistance statistics therefore aid in determining optimal patient care. Consequently, the purpose of this research was to examine the antimicrobial resistance pattern of third-generation cephalosporin medications at Jimma University Specialized Teaching Hospital. Methods. From April to August 2016, researchers at Jimma University Specialized Hospital (JUSH) performed a prospective cross-sectional study in a hospital setting. Patients in hospitals had their urine, sputum, wound swabs, and feces collected for clinical purposes. Following this, the usual microbiological procedures were followed in order to isolate and identify the bacterial species. Using the Kirby-Bauer disc diffusion technique, we tested the susceptibility of different microorganisms to antimicrobials. Final product. Out of a total of 248 bacterial isolates, 154 (62.1%) were found in male patients and 94 (37.0%) were found in female patients. Specimens were most often found to include Escherichia coli (25.4% of the total) and Staphylococcus aureus (19.0%). Approximately 56.5% of the total bacterial isolates (140) and 60.1% (149) were determined to be ceftriaxone and ceftazidime resistant, respectively. Most of the Escherichia coli isolates were resistant to ceftriaxone (73%) and ceftazidime (65%), with 41 (65%) of the isolates showing resistance to both drugs. Of all the germs tested, 19% were Staphylococcus aureus, and of those, 23.4 percent were resistant to ceftriaxone and 33.4 percent to ceftazidime, respectively. Out of the bacterial strains that showed resistance to ceftriazone and ceftazidime, about 109 (44% of the total) were also resistant to two, three, or four additional medicines. In summary. More and more bacterial strains are showing resistance to thirdgeneration cephalosporins, such as ceftriaxone and ceftazidime. This indicates that the problem is becoming worse. Treatment may fail because some bacteria have shown multidrug resistance, especially to medicines used in clinical settings. Thus, antimicrobial susceptibility test results should inform the selection of suitable drugs for clinical usage
DO  - 10.46243/jst.2025.v10.i6.pp37-47
UR  - https://doi.org/10.46243/jst.2025.v10.i6.pp37-47
ER  -

⬇ .ris

CSL-JSON

{
    "type": "article-journal",
    "id": "10.46243/jst.2025.v10.i6.pp37-47",
    "DOI": "10.46243/jst.2025.v10.i6.pp37-47",
    "URL": "https://doi.org/10.46243/jst.2025.v10.i6.pp37-47",
    "title": "AntimicrobialResistanceProfileofDifferentClinicalIsolatesagainstThird-GenerationCephalosporins",
    "source": "Smart Scholars Registry",
    "container-title": "Journal of Science & Technology",
    "author": [
        {
            "family": "DRBVRAMANA"
        },
        {
            "family": "S.K.RUBINA"
        },
        {
            "family": "DRMSANTOSHRAJA"
        },
        {
            "family": "AHEMANTH"
        },
        {
            "family": "S.AFREENJEHA"
        }
    ],
    "issued": {
        "date-parts": [
            [
                2025,
                6,
                20
            ]
        ]
    },
    "volume": "10",
    "issue": "06",
    "page": "37-47",
    "publisher": "Longman Publishers",
    "language": "en",
    "abstract": "death because they increase the likelihood of harmful treatment. Antimicrobial resistance statistics therefore aid in determining optimal patient care. Consequently, the purpose of this research was to examine the antimicrobial resistance pattern of third-generation cephalosporin medications at Jimma University Specialized Teaching Hospital. Methods. From April to August 2016, researchers at Jimma University Specialized Hospital (JUSH) performed a prospective cross-sectional study in a hospital setting. Patients in hospitals had their urine, sputum, wound swabs, and feces collected for clinical purposes. Following this, the usual microbiological procedures were followed in order to isolate and identify the bacterial species. Using the Kirby-Bauer disc diffusion technique, we tested the susceptibility of different microorganisms to antimicrobials. Final product. Out of a total of 248 bacterial isolates, 154 (62.1%) were found in male patients and 94 (37.0%) were found in female patients. Specimens were most often found to include Escherichia coli (25.4% of the total) and Staphylococcus aureus (19.0%). Approximately 56.5% of the total bacterial isolates (140) and 60.1% (149) were determined to be ceftriaxone and ceftazidime resistant, respectively. Most of the Escherichia coli isolates were resistant to ceftriaxone (73%) and ceftazidime (65%), with 41 (65%) of the isolates showing resistance to both drugs. Of all the germs tested, 19% were Staphylococcus aureus, and of those, 23.4 percent were resistant to ceftriaxone and 33.4 percent to ceftazidime, respectively. Out of the bacterial strains that showed resistance to ceftriazone and ceftazidime, about 109 (44% of the total) were also resistant to two, three, or four additional medicines. In summary. More and more bacterial strains are showing resistance to thirdgeneration cephalosporins, such as ceftriaxone and ceftazidime. This indicates that the problem is becoming worse. Treatment may fail because some bacteria have shown multidrug resistance, especially to medicines used in clinical settings. Thus, antimicrobial susceptibility test results should inform the selection of suitable drugs for clinical usage",
    "ISSN": "2456-5660"
}

⬇ .json What citeproc and reference managers read; the DOI system hands it out for Accept: application/vnd.citationstyles.csl+json, and so does this registry's resolver.

From the record as registered (version 2) — the record and its history. Programs: https://registry.smartscholars.in/api.php?action=cite&doi=10.46243%2Fjst.2025.v10.i6.pp37-47 gives all four in one JSON answer.

Share this page

Share this page

Ask AI about this page

Everything Smart Scholars runs

Nine sites, one account. A journal starts at the audit; an author starts at Scholar Shield.

What we do: DOIs registered from what a journal already has · Crossref records completed — references, abstracts, licences, ORCID iDs, affiliations and ROR IDs, funding · DOIs that resolve · articles preserved · journals rated on the public record · see everything we do →

Book a free call

For journals & publishers

Start with the audit — ₹4,999 per journal, and the gate to everything else.

DOI care

Every service on one journal profile — each previews first and acts only on your approval.

  • DOI Doctor — check & repairevery DOI tested at doi.org and Crossref; dead links, abstracts, licences, ORCIDs
  • Smart Deposita new DOI from your PDF, Word file, article page, JATS XML or spreadsheet — every value shown with its source, deposited once you confirm it
  • DOI census (Excel)site against Crossref, both directions, with a copy-paste fix per article
  • Backfile DOIsDOIs for older articles that never had one — no per-DOI fee of ours
  • DOIs for conference proceedingsthe conference, the volume and every paper — registered in the organiser's own name
  • Scopus indexing guidethe minimum criteria, the 14 CSAB criteria and how a title is suggested — from Elsevier's own page
  • Embase indexing guidewhat Embase asks of a biomedical journal and how to suggest it
  • Write DOIs into OJSthe verified DOIs pushed onto your article pages through your own API
  • Silent-failure monitorweekly checks of site, OAI-PMH, Scholar tags, ISSN, preservation, hijack lists
  • Journal Radarevery journal, every day: SSL, DNS, redirects, robots.txt, OJS, DOIs, Crossref metadata, broken links — what broke since yesterday first
  • Verified metrics & badgesa public, dated, source-linked metrics page and a "cited by" badge
  • Quality dossier (PDF)one PDF for universities, authors and reviewers
  • Author citation enginethe citation steps emailed to each author from the journal's own mailbox
  • JATS XMLmachine-readable JATS per article
  • Duplicate articlesthe same paper published twice — you choose which copy stays

For authors & researchers

Free to use. Nothing you check is shared with the journal.

For institutions, sponsors & DOI operators

Smart Scholars

Mon–Sat, 10:00–19:00 IST. The Ask AI button on every page answers about our services at any hour.

News

Policies

What we can register a DOI for

20 kinds of record, one account, one place. Every one gets a DOI that resolves, metadata that indexes read, and a record that stays correct afterwards.

Journals

  • Journal articles
  • Journal titles
  • Pending publications
  • Peer reviews
  • Preprints & posted content

Books & conferences

  • Books
  • Book chapters
  • Book series
  • Book sets
  • Conference proceedings
  • Proceedings series
  • Conference papers

Other research output

  • Theses & dissertations
  • Reports & working papers
  • Report series
  • Standards
  • Databases
  • Datasets
  • Figures, tables & supplements

Funding

  • Grants & funding awards

Elsewhere

The same company, in the places our publishers already read.
Add Smart Scholars as a preferred source on GoogleSee more of our newsroom in Google’s Top Stories.
Smart Scholars · Every service on one pageNewsroom posts CC BY 4.0 · DOI metadata CC0 · everything else ©Data from OpenAlex (openalex.org), CC0 · Crossref · ISSN Portal · DOAJContact
WhatsApp